We are very excited to share with you a sneak peek of a new investing research product in development.

It’s The Call @ Hedgeye – we think you’re going to like it.

In a nutshell, The Call @ Hedgeye is an online, video presentation distilling our morning research conference call with our entire team of analysts. Hedgeye CEO Keith McCullough hosts the call with our 40+ strong research analyst team.

All of the Hedgeye analysts share their latest perspective on the stocks within their respective sectors—across Technology, Retail, Industrials, Cannabis, Energy and much more.

Today on The Call @ Hedgeye, Healthcare analyst Tom Tobin and Healthcare Policy analyst Emily Evans discuss the FDA approval of Hydrochloroquine for COVID-19 care, the President’s latest COVID-19 briefing and COVID-19 case volume and its impact on reopening of the economy, Financials and Housing analyst Josh Steiner updates on his Visa/MasterCard cross border tracker, the TED spread, and the state of play for independent mortgage brokers given the Fed’s moves, Industrials analyst Jay Van Sciver talks Illinois Tool Works (ITW), and Communications analyst Andrew Freedman talks Altice (ATUS) and his field note on the production gap emerging in TV and Film production.

Our goal since Day One, over a decade ago, has been to level the investing playing field by bringing hedge fund quality research to everyday investors.

We are doing it.

*Please keep in mind The Call @ Hedgeye is in development stage. We are still experimenting with a number of things before its official launch. In the meantime, we would love to hear your thoughts! Email info@hedgeye.com to provide your feedback.

Click HERE to listen to the “Complete Audio” of The Call @ Hedgeye. Please stayed tuned after the audio segment of The Call for our brief disclaimer.